Patient management by Neoral® C² monitoring: from science to practiceMONACO, Anthony P.Transplantation. 2002, Vol 73, Num 9, issn 0041-1337, 23 p., SUPSerial Issue

Cyclosporine formulations : Is there really a difference?MASRI, M. A; STEPHAN, A; BARBARI, A et al.Transplantation proceedings. 2000, Vol 32, Num 7, pp 1468-1469, issn 0041-1345Conference Paper

Abbreviated AUC strategy for monitoring cyclosporine microemulsion therapy in the immediate posttransplant periodAMANTE, A. J; KAHAN, B. D.Transplantation proceedings. 1996, Vol 28, Num 4, pp 2162-2163, issn 0041-1345Conference Paper

Comparison of neoral and Sandimmune preparations in renal transplant patients : Improved pharmacokinetics with neoralWARRENS, A. N; SALAMA, A; WATERS, J. B et al.Transplantation proceedings. 1996, Vol 28, Num 4, pp 2169-2170, issn 0041-1345Conference Paper

Conversion from Sandimmune to neoral in stable renal and pancreas transplant recipients enhances cyclosporine absorptionCHAPMAN, J. R; O'CONNELL, P. J; BOVINGTON, K. J et al.Transplantation proceedings. 1996, Vol 28, Num 4, pp 2293-2295, issn 0041-1345Conference Paper

Conversion from Sandimmune to neoral in stable renal transplant recipientsPESCOVITZ, M. D.Transplantation proceedings. 1996, Vol 28, Num 4, pp 2195-2198, issn 0041-1345, 3 p.Conference Paper

Induction of immunosuppression by microemulsion cyclosporine in liver transplantationRASMUSSEN, A; HJORTRUP, A; HAUSEN, B et al.Transplantation. 1996, Vol 62, Num 7, pp 1031-1033, issn 0041-1337Article

Experience with new cyclosporine formulations : Consupren and neoral in renal transplant patientsBARBARI, A; STEPHAN, A; KAMEL, G et al.Transplantation proceedings. 1997, Vol 29, Num 7, pp 2941-2944, issn 0041-1345Conference Paper

Case reports on conversion to neoral therapy in renal transplant patientsCURTIS, J. J.Transplantation proceedings. 1996, Vol 28, Num 4, pp 2221-2222, issn 0041-1345Conference Paper

Neoral therapy in liver transplantationLEVY, G. A.Transplantation proceedings. 1996, Vol 28, Num 4, pp 2225-2228, issn 0041-1345Conference Paper

Successful reconversion from tacrolimus to cyclosporine A neoral in pediatric liver recipientsMELTER, M; RODECK, B; KARDORFF, R et al.Transplantation proceedings. 1996, Vol 28, Num 4, pp 2276-2278, issn 0041-1345Conference Paper

Administration diluents differentiate Neoral from a generic cyclosporine oral solutionKOVARIK, John M; BARILLA, Denise; MCMAHON, Louis et al.Clinical transplantation. 2002, Vol 16, Num 4, pp 306-309, issn 0902-0063Article

Conversion from sandimmune to neoral in stable pediatric liver transplant recipientsZYLBER-KATZ, E; DORON, D; GRANOT, E et al.Transplantation proceedings. 1999, Vol 31, Num 4, pp 1915-1917, issn 0041-1345Conference Paper

Increased dosage requirement and rejection after neoral conversion in pediatric liver transplant patientsCAO, S; COX, K. L; BERQUIST, W et al.Transplantation proceedings. 1998, Vol 30, Num 8, pp 4322-4324, issn 0041-1345Conference Paper

Pharmaco-economic study of FK 506 (prograf) and cyclosporine A neoral in cadaveric renal transplantationMORRIS-STIFF, G; RICHARDS, T; SINGH, J et al.Transplantation proceedings. 1998, Vol 30, Num 4, pp 1285-1286, issn 0041-1345Conference Paper

Microemulsion formulation of cyclosporine in pediatric liver transplantationALBERTI, D; WALLEMACQ, P; FALCHETTI, D et al.Transplantation. 1996, Vol 61, Num 3, pp 512-514, issn 0041-1337Article

Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipientsDILIZ, H. S; OLIVERA, M. A; KERSHENOBICH, D et al.Transplantation proceedings. 1996, Vol 28, Num 6, pp 3348-3350, issn 0041-1345Conference Paper

Pharmacokinetic analysis of neoral conversion in pediatric and adult renal transplant recipients with poor absorption of sandimmunePESCOVITZ, M. D; HENSON, S; BODZIAK, K et al.Transplantation proceedings. 1996, Vol 28, Num 4, pp 2165-2168, issn 0041-1345Conference Paper

Safety and tolerability of neoral in transplant recipientsFEUTREN, G; WONG, R; JIN, J et al.Transplantation proceedings. 1996, Vol 28, Num 4, pp 2177-2182, issn 0041-1345Conference Paper

Use of neoral in pediatric renal transplantationETTENGER, R. E; SMITH, H. T; KAISER, B et al.Transplantation proceedings. 1996, Vol 28, Num 4, pp 2257-2258, issn 0041-1345Conference Paper

C0 or C2 driven cyclosporine monitoring in long-term pediatric kidney transplant recipients : Is there any threat for chronic rejection development?FERRARESSO, Mariano; GHIO, Luciana; EDEFONTI, Alberto et al.Pediatric transplantation. 2005, Vol 9, Num 3, pp 328-331, issn 1397-3142, 4 p.Article

A large, multicentre trial to compare the efficacy and safety of tacrolimus with cyclosporine microemulsion following renal transplantationSPERSCHNEIDER, H.Transplantation proceedings. 2001, Vol 33, Num 1-2, pp 1279-1281, issn 0041-1345Conference Paper

Neoral monitoring : Limitations of trough level monitoring and the potential role of limited sampling strategiesCOLE, E. H.Transplantation proceedings. 2000, Vol 32, Num 7, pp 1556-1558, issn 0041-1345Conference Paper

Pharmacokinetic and safety evaluation of sangcya vs neoral or sandimmune in stable renal transplant recipientsGASTON, R; ALLOWAY, R. R; GABER, A. O et al.Transplantation proceedings. 1999, Vol 31, Num 1-2, pp 326-327, issn 0041-1345Conference Paper

Pharmacokinetic comparison of two cyclosporine a formulations, SangCya (Sang-35) and neoral, in stable adult liver transplant recipientsFISHER, R. A; PAN, S.-H; ROSSI, S. J et al.Transplantation proceedings. 1999, Vol 31, Num 1-2, pp 394-395, issn 0041-1345Conference Paper